| Tissue distribution of the opioid receptor-like (ORL1) receptor C Mollereau, L Mouledous Peptides 21 (7), 907-917, 2000 | 294 | 2000 |
| Protein degradation, as with protein synthesis, is required during not only long‐term spatial memory consolidation but also reconsolidation J Artinian, AMT McGauran, X De Jaeger, L Mouledous, B Frances, ... European Journal of Neuroscience 27 (11), 3009-3019, 2008 | 173 | 2008 |
| Central Apelin Controls Glucose Homeostasis via a Nitric Oxide-Dependent Pathway in Mice T Duparc, A Colom, PD Cani, N Massaly, S Rastrelli, A Drougard, ... Antioxidants & redox signaling 15 (6), 1477-1496, 2011 | 104 | 2011 |
| Molecular modelling of the ORL1 receptor and its complex with nociceptin. CM Topham, L Moulédous, G Poda, B Maigret, JC Meunier Protein engineering 11 (12), 1163-1179, 1998 | 96 | 1998 |
| Distinct mechanisms for activation of the opioid receptor-like 1 and κ-opioid receptors by nociceptin and dynorphin A C Mollereau, L Mouledous, S Lapalu, G Cambois, C Moisand, JL Butour, ... Molecular pharmacology 55 (2), 324-331, 1999 | 93 | 1999 |
| Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments K Elhabazi, JM Trigo, C Mollereau, L Moulédous, JM Zajac, F Bihel, ... British journal of pharmacology 165 (2), 424-435, 2012 | 89 | 2012 |
| The nociceptin (ORL1) receptor: molecular cloning and functional architecture JC Meunier, L Mouledous, CM Topham Peptides 21 (7), 893-900, 2000 | 85 | 2000 |
| Opioid‐modulating properties of the neuropeptide FF system L Moulédous, C Mollereau, JM Zajac Biofactors 36 (6), 423-429, 2010 | 82 | 2010 |
| Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples L Moulédous, S Hunt, R Harcourt, J Harry, KL Williams, HB Gutstein Proteomics 3 (5), 610-615, 2003 | 70 | 2003 |
| Proteomic analysis of immunostained, laser‐capture microdissected brain samples L Moulédous, S Hunt, R Harcourt, JL Harry, KL Williams, HB Gutstein Electrophoresis 24 (1‐2), 296-302, 2003 | 64 | 2003 |
| GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors L Moulédous, C Froment, S Dauvillier, O Burlet-Schiltz, JM Zajac, ... Journal of Biological Chemistry 287 (16), 12736-12749, 2012 | 54 | 2012 |
| Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed … L Mouledous, CM Topham, C Moisand, C Mollereau, JC Meunier Molecular Pharmacology 57 (3), 495-502, 2000 | 53 | 2000 |
| Loss of morphine reward and dependence in mice lacking G protein–coupled receptor kinase 5 L Glück, A Loktev, L Moulédous, C Mollereau, PY Law, S Schulz Biological psychiatry 76 (10), 767-774, 2014 | 49 | 2014 |
| Long-term morphine treatment enhances proteasome-dependent degradation of Gβ in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization L Moulédous, J Neasta, S Uttenweiler-Joseph, A Stella, M Matondo, ... Molecular pharmacology 68 (2), 467-476, 2005 | 47 | 2005 |
| Mitochondria in developmental and adult neurogenesis MS Arrázola, T Andraini, M Szelechowski, L Mouledous, ... Neurotoxicity Research 36 (2), 257-267, 2019 | 44 | 2019 |
| Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa10, Tyr14] nociceptin L Moulédous, CM Topham, H Mazarguil, JC Meunier Journal of Biological Chemistry 275 (38), 29268-29274, 2000 | 38 | 2000 |
| Roles of the ubiquitin proteasome system in the effects of drugs of abuse N Massaly, B Francès, L Moulédous Frontiers in molecular neuroscience 7, 99, 2015 | 36 | 2015 |
| Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice L Moulédous, F Barthas, JM Zajac Neuropeptides 44 (5), 453-456, 2010 | 36 | 2010 |
| Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists A Mann, L Moulédous, C Froment, PR O’Neill, P Dasgupta, T Günther, ... Science signaling 12 (574), eaau8072, 2019 | 35 | 2019 |
| Involvement of protein degradation by the ubiquitin proteasome system in opiate addictive behaviors N Massaly, L Dahan, M Baudonnat, C Hovnanian, K Rekik, M Solinas, ... Neuropsychopharmacology 38 (4), 596-604, 2013 | 32 | 2013 |
Claire RamponCNRS Research Director, CRCA CBI (CNRS-UT3), TMBI (Univ. Toulouse)E-mail megerősítve itt: univ-tlse3.fr
